When is chemotherapy recommended for bladder cancer?

For some non-muscle-invasive bladder cancers, medicine may be placed directly into the bladder after a procedure to remove the visible tumour. This local treatment is intended to lower the chance of the tumour returning in the bladder. For muscle-invasive disease, chemotherapy may be given through a vein before surgery or radiotherapy to treat possible cancer cells elsewhere and shrink the tumour. It may also be considered after surgery in selected situations. When bladder cancer has spread or cannot be removed, systemic chemotherapy can be used to control the disease and symptoms, sometimes alongside other medicines.

Your team will review the biopsy, bladder scans, kidney function, hearing, nerves, blood counts and other health conditions. Kidney function is especially relevant to some chemotherapy medicines. Tell the team about urinary symptoms, infections, numbness, hearing changes, heart problems, medicines and supplements. Ask whether treatment is given into the bladder or through a vein, how many visits are expected, and what happens if a dose needs to be delayed.

Seek prompt advice for fever or chills, inability to pass urine, worsening blood or clots in urine, severe pain, repeated vomiting or very little urine. Get emergency help for fainting, breathing difficulty, confusion or heavy bleeding. After medicine placed in the bladder, burning can occur, but severe or persistent urinary symptoms need assessment.

Has my tumour entered the bladder muscle, and what does that mean for chemotherapy? Which route is planned, and how will kidney function or hearing affect the choice? What symptoms should I report between visits?